title: Putting a cost on extra days given by drugs.
authors.forename: Jack W
authors.initials: JW
authors.lastname: Singer
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics*; D000970:Antineoplastic Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C422802:ibritumomab tiuxetan; C119496:tositumomab I-131